Prochaska JH, Hausner C, Nagler M, Göbel S, Eggebrecht L, Panova-Noeva M, Arnold N, Lauterbach M, Bickel C, Michal M, Hardt R, Espinola-Klein C, Lackner KJ, Münzel T, Wild PS. Subtherapeutic Anticoagulation Control under Treatment with Vitamin K-Antagonists-Data from a Specialized Coagulation Service. Thrombosis and Haemostasis. 2019 Jun 10

Eggebrecht L, Nagler M, Göbel S, Lamparter H, Keller K, Wagner B, Panova-Noeva M, Ten Cate V, Bickel C, Lauterbach M, Espinola-Klein C, Hardt R, Münzel T, Prochaska JH, Wild PS. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists. Journal of the American Geriatrics Society. 2019 Mar;67(3):463-70 


Göbel S, Prochaska JH, Eggebrecht L, Schmitz R, Jünger C, Lamparter H, Nagler M, Keller K, Coldewey M, Tröbs SO, Diestelmeier S, Schwuchow-Thonke S, Bickel C, Lauterbach M, Lackner KJ, Cate HT, Münzel T, Hardt R, Wild PS. Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study. Thrombosis and Haemostasis. 2018 Nov;118(11):1930-1939

Prochaska JH, Göbel S, Nagler M, Knöpfler T, Eggebrecht L, Lamparter H, Panova-Noeva M, Keller K, Coldewey M, Bickel C, LAuterbach M, Hardt R, Espinola-Klein C, ten Cate H, Rostock T, Münzel T, Wild PS. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure. Clinical Research in Cardiology. 2018 Jun 9

Eggebrecht L, Prochaska JH, Schleuter L, Nagler M, Hardt R, Schinzel H, Münzel T, Wild PS. [Physicians´Opinion on Health Care in Oral Anticoagulants] Deutsche Medizinische Wochenschrift 2018 May; 143(9):e76-e84


Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Schulz A, Schinzel H, Bickel C, Lauterbach M, Michal M, Hardt R, Binder H, Espinola-Klein C, Lackner KJ, Ten Cate H, Münzel T, Wild PS. e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study. Journal of Thrombosis and Haemostasis. 2017 Jul; 15(7):1375-1385


Keller K, Prochaska JH, Coldewey M, Göbel S, Ullmann A, Jünger C, Lamparter H, Ariza L, Bickel C, Lauterbach M, Konstantinides S, Rostock T, Münzel T and Wild PS. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism. Thrombosis research. 2015 Nov;136:899-906.

Michal M, Prochaska JH, Keller K, Göbel S, Coldewey M, Ullmann A, Schulz A, Lamparter H, Münzel T, Reiner I, Beutel ME and Wild PS.  Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program. International journal of cardiology. 2015;187:614-9.

Zolfaghari S, Harenberg J, Frölich L, Weiss C, Wehling M, Wild P, Prochaska J, Bayer-Westendorf J, Koscielny J, Lip GY. Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients´preference. Seminars in Thrombosis and Hemostasis. 2015 Mar;41(2):166-77.

Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Jünger C, Al-Bayati Z, Baer C, Walter U, Bickel C, ten Cate H, Münzel T and Wild PS. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL. BMC medicine. 2015 Jan 23;13:14.

Prochaska JH, Coldewey M, Göbel S, Keller K, Hendelmeier M, Konstantinides S, Münzel T and Wild PS. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme. European journal of preventive cardiology. 2015 May;22:622-8.


Michal M, Prochaska JH, Ullmann A, Keller K, Göbel S, Coldewey M, Münzel T, Wiltink J, Beutel ME and Wild PS. Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program. Journal of thrombosis and haemostasis : JTH. 2014 Dec;12:2024-33.